Clinical Trial Update: Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing increasing doses of idarubicin and cytarabine with G-CSF in de novo acute myeloid leukemia, reporting efficacy and toxicity out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• G-CSF (granulocyte colony-stimulating factor)
• Idarubicin (idarubicin)

Snippet

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | Conditions: Di Novo Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED